首页> 外国专利> NOVEL BIOMARKER AND NOVEL TREATMENT VACCINE FOR TYPE 1 DIABETES MELLITUS

NOVEL BIOMARKER AND NOVEL TREATMENT VACCINE FOR TYPE 1 DIABETES MELLITUS

机译:1型糖尿病患者的新型生物标志物和新型治疗疫苗

摘要

PROBLEM TO BE SOLVED: To provide an inspection method of type 1 diabetes mellitus and a vaccine for prevention or treatment of the type 1 diabetes mellitus.;SOLUTION: There is provided an inspection method of type 1 diabetes mellitus containing measurement of an autoantibody of (1) or (2), from a sample derived from a subject: (1) is an autoantibody with respect to a peptide formed of an amino acid sequence indicated in a sequence number:2 or a peptide formed of an amino acid sequence corresponding to a sequence number:2 in a nonhuman mammal; and (2) is an autoantibody with respect to a peptide formed of an amino acid sequence indicated in a sequence number:2, or a peptide formed of an amino acid sequence corresponding to a sequence number:2 in a nonhuman mammal, in the amino acid sequence, one or several amino acid residues are substituted, deleted, inserted or added.;SELECTED DRAWING: None;COPYRIGHT: (C)2017,JPO&INPIT
机译:解决的问题:提供一种1型糖尿病的检查方法以及一种预防或治疗1型糖尿病的疫苗。解决方案:提供一种1型糖尿病的检查方法,其中包含对自身抗体的测量( (1)或(2),其来自受试者的样品:(1)是相对于由序列号:2所示的氨基酸序列形成的肽或由与之对应的氨基酸序列形成的肽的自身抗体。序列号:2在非人类哺乳动物中; (2)是关于在非人类哺乳动物中由序列号:2所示的氨基酸序列形成的肽或由与序列号:2对应的氨基酸序列形成的肽的自身抗体。氨基酸序列,一个或几个氨基酸残基被取代,删除,插入或添加。;选择制图:无;版权:(C)2017,JPO&INPIT

著录项

  • 公开/公告号JP2017040544A

    专利类型

  • 公开/公告日2017-02-23

    原文格式PDF

  • 申请/专利权人 OSAKA UNIV;

    申请/专利号JP20150162065

  • 申请日2015-08-19

  • 分类号G01N33/53;A61K39/00;A61K39/12;A61P3/10;A61K39/21;A61K39/235;A61K39/39;G01N33/50;C07K14/47;

  • 国家 JP

  • 入库时间 2022-08-21 14:00:43

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号